Volitionrx (VNRX) Non Operating Income (2019 - 2024)
Volitionrx (VNRX) posted Non Operating Income of -$87501.0 for Q1 2024, down 47.99% on a QoQ basis from -$59126.0 in Q4 2023, and down 150.84% year-over-year from $172121.0 in Q2 2023.
Volitionrx (VNRX) Non Operating Income (2019 - 2024) Analysis & Trends
Volitionrx's Non Operating Income history runs 6 years deep, the most recent figure standing at -$87501.0 for Q1 2024.
- Quarterly Non Operating Income fell 150.84% year-over-year to -$87501.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $50999.0 (down 96.34% YoY) and the FY2023 annual result came in at $310621.0, down 73.71% from the prior year.
- Non Operating Income was -$87501.0 for Q1 2024 at Volitionrx, down from -$59126.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $676795.0 in Q4 2021 and bottomed at -$87501.0 in Q1 2024.
- A 5-year average of $211561.4 and a median of $172121.0 in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income sank 422.16% — and 2023, when it jumped 519.5%.
- Volitionrx's Non Operating Income stood at $498205.0 in 2020, then jumped by 35.85% to $676795.0 in 2021, then dropped by 0.34% to $674476.0 in 2022, then plunged by 108.77% to -$59126.0 in 2023, then sank by 47.99% to -$87501.0 in 2024.
- Business Quant data shows VNRX's Non Operating Income at -$87501.0 in Q1 2024, -$59126.0 in Q4 2023, and $199867.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -87,501.00 |
| Dec 31, 2023 | -59,126.00 |
| Sep 30, 2023 | 199,867.00 |
| Jun 30, 2023 | -2,241.00 |
| Mar 31, 2023 | 172,121.00 |
| Dec 31, 2022 | 674,476.00 |
| Sep 30, 2022 | 180,685.00 |
| Jun 30, 2022 | 367,472.00 |
| Mar 31, 2022 | -41,030.00 |
| Dec 31, 2021 | 676,795.00 |
| Sep 30, 2021 | 380,794.00 |
| Jun 30, 2021 | 326,170.00 |
| Mar 31, 2021 | -40,460.00 |
| Dec 31, 2020 | 498,205.00 |
| Sep 30, 2020 | 168,472.00 |
| Jun 30, 2020 | 169,285.00 |
| Mar 31, 2020 | 12,559.00 |
| Mar 31, 2019 | -215,494.00 |